Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial
- DOI
- 10.1016/s1474-4422(26)00214-0
- Published
- 2026-09
- Container
- The Lancet Neurology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-26-00214-0,
title = {Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial},
author = {Uwe Reuter and Annelies Van Dycke and Jan Versijpt and Dagny Holle-Lee and Mark Kristof Farkas and Stewart J Tepper and Giovanna Forero and Lei Luo and Hua Guo and Eric Cohen and Brett Dabruzzo and Pranav Gandhi and Krisztian Nagy},
year = {2026},
journal = {The Lancet Neurology},
doi = {10.1016/s1474-4422(26)00214-0},
url = {https://doi.org/10.1016/s1474-4422(26)00214-0}
}RIS
TY - JOUR TI - Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial AU - Uwe Reuter AU - Annelies Van Dycke AU - Jan Versijpt AU - Dagny Holle-Lee AU - Mark Kristof Farkas AU - Stewart J Tepper AU - Giovanna Forero AU - Lei Luo AU - Hua Guo AU - Eric Cohen AU - Brett Dabruzzo AU - Pranav Gandhi AU - Krisztian Nagy PY - 2026 JO - The Lancet Neurology DO - 10.1016/s1474-4422(26)00214-0 UR - https://doi.org/10.1016/s1474-4422(26)00214-0 ER -
APA
Reuter, U., Dycke, A. V., Versijpt, J., Holle-Lee, D., Farkas, M. K., Tepper, S. J., Forero, G., Luo, L., Guo, H., Cohen, E., Dabruzzo, B., Gandhi, P., & Nagy, K. (2026). Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(26)00214-0
Source records
- crossref · retrieved 2026-09-26T10:17:26.084Z